Effectiveness of levamisole in the treatment of patients with severe COVID-19: a randomized controlled clinical trial
Administering levamisole to hospitalized patients with severe COVID-19 reduced hospitalization time and improved several clinical outcomes.
Authors
- Rasool Soltani (ORCID: https://orcid.org/0000-0001-9301-4732)
- Fatemeh Nikokar (ORCID: https://orcid.org/0000-0003-2155-9973)
- Mehran Noroozi (ORCID: https://orcid.org/0000-0002-3021-1859)
- Morteza Pourahmad (ORCID: https://orcid.org/0000-0003-1946-2953)
- Farzin Khorvash (ORCID: https://orcid.org/0000-0003-2542-9885)
- Manijeh Shams
- Behrooz Ataei (ORCID: https://orcid.org/0000-0001-5239-5102)
Institutions
- Isfahan University of Medical Sciences (IR)
- Alzahra Medical and Education Center (IR)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-12-31
- DOI
- https://doi.org/10.3855/jidc.18659
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- Isfahan University of Medical Sciences